These short-term side effects usually resolve within 4-8 weeks
In clinical trials, the safety profile of semaglutide 7.2 mg was generally consistent with lower doses
Furthermore, the EMA has withdrawn the weight loss medication rimonabant, a selective cannabinoid type 1 receptor antagonist, due to its reported links to increased risks of depression and suicide [70]
Semaglutide may interfere with the balance between bacteria and yeast by slowing gastrointestinal transit, provoking GI side effects that change gut flora, and, through rapid weight loss, changing hormones that help maintain vaginal health
Anxiety can trigger emotional eating, increase cortisol levels (which promotes fat storage around the abdomen), and reduce motivation for physical activity